View Author
patient myeloma bortezomib response treatment therapy group blood study trial university dexamethasone regimen month survival thalidomide analysis number result outcome cancer hospital hovon lenalidomide table chromosomal aberrations prognostic center department aberration cell transplantation chromosomal phase disease cycle factor germany erasmus mc signi arm b richardson ϩ1 q 21 stage transplantation absct high-dose response rates medicine effect signi ficantly high-dose dexamethasone hematology myeloma sk kumar figure leukemia abnormality gmmg-hd autologou fi rst absct cd 34 þ diagnosis mm patients institute response rate -50 transplant article duration january combination heidelberg pfs time mobilization fi rst regimen iss score kumar erasmu event-free survival induction regimen myeloma patients
4 Most Recent Publications
|
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p
(Article)
Neben, K. Lokhorst, H.M. Scheid, C. Dührsen, U. Lindemann, W. Schmidt-Wolf, I.G.H. Peter, N. Teschendorf, C. Martin, H. Haenel, M. Derigs, H.G. Raab, M.S. Jauch, A. Ho, A.D. Velde, C.J.H. van de Hose, D. Sonneveld, P. Goldschmidt, H. Bertsch, U. Hielscher, T. Holt, B.D. van Salwender, H. Blau, I.W. Weisel, K. Pfreundschuh, M. |
2012-01-26
|
|
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
(Article)
Kumar, S. Lee, J.H. Leleu, X. Hulin, C. Klein, S.K. Sonneveld, P. Siegel, D. Bladé, J. Goldschmidt, H. Jagannath, S. Miguel, J.S. Orlowski, R.Z. Lahuerta, J.J. Palumbo, A. Sezer, O. Rajkumar, S.V. Durie, B.G.M. Morgan, G. Richardson, P.G. Crowley, J. Haessler, J. Feather, J. Hoering, A. Moreau, P. |
2012-01-01
|
|
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: Final time-to-event results of the APEX trial
(Article)
Richardson, P.G. Sonneveld, P. Reece, D. San Miguel, J-F. Bladé, J. Boccadoro, M. Cavenagh, J. Alsina, M. Rajkumar, S.V. Lacy, M. Jakubowiak, A.J. Dalton, W. Schuster, M.W. Boral, A.L. Esseltine, D-L. Schenkein, D. Anderson, K.C. Irwin, D. Stadtmauer, E.A. Facon, T. Harousseau, J-L. Ben-Yehuda, D. Lonial, S. Goldschmidt, H. |
2007-11-15
|
|
Thalidomide in newly diagnosed multiple myeloma: Influence of thalidomide treatment on peripheral blood stem cell collection yield
(Article)
Breitkreutz, I. Lokhorst, H.M. Salwender, H. Haenel, A. Sonneveld, P. Goldschmidt, H. Raab, M.S. Holt, B. van der Cremer, F.W. Herrmann, D. Glasmacher, A. Schmidt-Wolf, I.G.H. Blau, I.W. Martin, H. |
2007-06-01
|
